Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. However, it is advised to contact the doctor immediately if you miss a scheduled dose of this medicine.
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Pegloticase (moderate)
This medicine is used for the treatment of a wet type of age-related macular degeneration, an eye disease that impairs central vision making difficult to read, drive, or perform other daily activities.
Blurred vision
Visual disturbances
Eye discomfort
Decreased vision
Swelling or inflammation of the eyelid (rare)
Eye irritation
Dryness of eyes
Redness of eye
Small particles or spots in your vision
This medicine is not recommended for use in patients with a known allergy to Macugen Soln 0.3 mg 1 mL or any other inactive ingredients present along with it.
This medicine is not recommended for use in patients with infectious eye diseases due to the increased risk of worsening of the patient's condition.